Jazz Pharmaceuticals PLC (JAZZ)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	560,120	463,159	394,924	330,794	414,832	80,727	-83,196	-152,969	-216,600	-12,000	-47,730	-445,711	-329,668	-160,903	40,164	518,281	238,616	179,194	133,236	280,333
Revenue (ttm)	US$ in thousands	4,068,943	3,992,713	3,909,883	3,843,380	3,834,209	3,794,392	3,762,904	3,738,465	3,659,374	3,583,982	3,481,445	3,300,378	3,094,238	2,863,024	2,625,797	2,436,422	2,363,567	2,279,790	2,216,604	2,188,301
Net profit margin		13.77%	11.60%	10.10%	8.61%	10.82%	2.13%	-2.21%	-4.09%	-5.92%	-0.33%	-1.37%	-13.50%	-10.65%	-5.62%	1.53%	21.27%	10.10%	7.86%	6.01%	12.81%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $560,120K ÷ $4,068,943K
= 13.77%

The net profit margin of Jazz Pharmaceuticals PLC has varied significantly over the analyzed period. It started at a healthy 12.81% on March 31, 2020, but experienced a notable decline to 6.01% by June 30, 2020. Subsequently, there was a modest recovery with margins reaching 10.10% by December 31, 2020.

The performance fluctuated further in the following quarters, showing a dip to -10.65% by December 31, 2021. However, there was a significant positive turnaround by March 31, 2023, where the net profit margin rose to 10.82%. The trend continued positively, with margins improving to 13.77% by December 31, 2024.

It is crucial for investors and stakeholders to closely monitor the net profit margin as it reflects the company's profitability and efficiency in managing its costs and expenses relative to its revenue. fluctuations in this ratio could indicate changes in the company's operational efficiency and overall financial health.